» Articles » PMID: 15920557

PLAG1 Gene Alterations in Salivary Gland Pleomorphic Adenoma and Carcinoma Ex-pleomorphic Adenoma: a Combined Study Using Chromosome Banding, in Situ Hybridization and Immunocytochemistry

Overview
Journal Mod Pathol
Specialty Pathology
Date 2005 May 28
PMID 15920557
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

Pleomorphic adenoma is the most common benign tumor of the salivary glands. It has marked histological diversity with epithelial, myoepithelial and mesenchymal-type cells arranged in a variety of architectural and differentiation patterns. Pleomorphic adenoma gene 1 (PLAG1), shown to be consistently rearranged in pleomorphic adenomas, is activated by chromosomal translocations involving 8q12, the chromosome region that is most frequently affected in these tumors. In this study, we evaluated PLAG1 involvement in salivary gland tumorigenesis by determining the frequency of its alterations in a selected group of 20 salivary gland tumors: 16 pleomorphic adenomas and four carcinomas ex-pleomorphic adenoma, having in common the presence of karyotypic chromosome 8 deviations, either structural, with 8q12 rearrangements, or numerical, with gain of chromosome 8. PLAG1 status was analyzed using in situ hybridization techniques, on metaphase cells, by fluorescence detection and/or interphase cells in paraffin sections, by chromogenic detection. Except for one pleomorphic adenoma case (5%) that lacked PLAG1 involvement, 17 tumors (85%), (14 pleomorphic adenomas and three carcinomas ex-pleomorphic adenoma) showed intragenic rearrangements of PLAG1 and the remaining two cases (10%), (one pleomorphic adenoma and one carcinoma ex-pleomorphic adenoma), had chromosome trisomy 8 only. To further investigate the role of PLAG1 on pleomorphic adenomas tumorigenesis, as well as the putative morphogenesis mechanism, we attempted to identify the cell types (epithelial vs myoepithelial) carrying 8q12/PLAG1 abnormalities by a combined phenotypic/genotypic analysis in four cases (three pleomorphic adenoma and one carcinoma ex-pleomorphic adenoma) characterized by 8q12 translocations and PLAG1 rearrangement. In these cases, both cells populations carried PLAG1 rearrangements. This finding further supports the pluripotent single-cell theory, which postulates that the tumor-initiated, modified myoepithelial cell, evolves into the varied somatic cell phenotypes present in pleomorphic adenoma, and reinforces the role of PLAG1 on the tumorigenesis of benign and malignant pleomorphic adenoma.

Citing Articles

Tyrosine crystal deposition in pleomorphic adenoma: a rare presentation in a male smoker with long-term follow-up.

Tamgadge S, Venkateshwar G, Pereira T, Tamgadge A, Pethani S Ecancermedicalscience. 2024; 18:1776.

PMID: 39430089 PMC: 11489107. DOI: 10.3332/ecancer.2024.1776.


Distinct copy number signatures between residual benign and transformed areas of carcinoma ex pleomorphic adenoma.

Scarini J, Sabino W, de Lima-Souza R, Egal E, Tincani A, Gondak R Sci Rep. 2024; 14(1):23645.

PMID: 39384827 PMC: 11464513. DOI: 10.1038/s41598-024-63763-9.


Proceedings of the 2024 North American Society of Head and Neck Pathology Companion Meeting, Baltimore, MD, March 24, 2024: Navigating Ancillary Studies in Basaloid/Blue Salivary Tumors.

Wong K Head Neck Pathol. 2024; 18(1):24.

PMID: 38526755 PMC: 10963686. DOI: 10.1007/s12105-024-01626-5.


Real-World Clinical Performance of a DNA-Based Comprehensive Genomic Profiling Assay for Detecting Targetable Fusions in Nonsquamous NSCLC.

Mack P, Keller-Evans R, Li G, Lofgren K, Schrock A, Trabucco S Oncologist. 2024; 29(8):e984-e996.

PMID: 38401173 PMC: 11299949. DOI: 10.1093/oncolo/oyae028.


Pleomorphic Adenoma with a Novel Gene Rearrangement-LINC01606::PLAG1.

Naik U, Amin S, Elsayad M, Saluja K Head Neck Pathol. 2024; 18(1):10.

PMID: 38393488 PMC: 10891012. DOI: 10.1007/s12105-024-01612-x.